IL128280A0 - Method fro treating bipolar disorder - Google Patents

Method fro treating bipolar disorder

Info

Publication number
IL128280A0
IL128280A0 IL12828097A IL12828097A IL128280A0 IL 128280 A0 IL128280 A0 IL 128280A0 IL 12828097 A IL12828097 A IL 12828097A IL 12828097 A IL12828097 A IL 12828097A IL 128280 A0 IL128280 A0 IL 128280A0
Authority
IL
Israel
Prior art keywords
bipolar disorder
treating bipolar
method fro
fro treating
disorder
Prior art date
Application number
IL12828097A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of IL128280A0 publication Critical patent/IL128280A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nonmetallic Welding Materials (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrolytic Production Of Non-Metals, Compounds, Apparatuses Therefor (AREA)
  • Press Drives And Press Lines (AREA)
  • Processing Of Solid Wastes (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
IL12828097A 1996-08-01 1997-07-28 Method fro treating bipolar disorder IL128280A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2290096P 1996-08-01 1996-08-01
PCT/US1997/013185 WO1998005324A1 (en) 1996-08-01 1997-07-28 Method for treating bipolar disorder

Publications (1)

Publication Number Publication Date
IL128280A0 true IL128280A0 (en) 1999-11-30

Family

ID=21812011

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12828097A IL128280A0 (en) 1996-08-01 1997-07-28 Method fro treating bipolar disorder

Country Status (19)

Country Link
EP (1) EP0821955B1 (de)
JP (1) JP2000515547A (de)
KR (1) KR20000029647A (de)
CN (1) CN1226165A (de)
AT (1) ATE213413T1 (de)
AU (1) AU716972B2 (de)
BR (1) BR9710901A (de)
CA (1) CA2261802C (de)
CZ (1) CZ27299A3 (de)
DE (1) DE69710526T2 (de)
DK (1) DK0821955T3 (de)
EA (1) EA199900174A1 (de)
ES (1) ES2171838T3 (de)
HU (1) HUP9904578A2 (de)
IL (1) IL128280A0 (de)
NO (1) NO990436L (de)
PL (1) PL331407A1 (de)
PT (1) PT821955E (de)
WO (1) WO1998005324A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
PT3061821T (pt) * 2009-07-22 2019-09-05 PureTech Health LLC Composições para tratamento de distúrbios melhorados por ativação de recetores muscarínicos
US20140206667A1 (en) 2012-11-14 2014-07-24 Michela Gallagher Methods and compositions for treating schizophrenia
KR102408292B1 (ko) 2018-09-28 2022-06-10 카루나 세러퓨틱스 인코포레이티드 무스카린성 수용체 활성화에 의해 개선된 장애의 치료를 위한 조성물 및 방법
CN111430027B (zh) * 2020-03-18 2023-04-28 浙江大学 基于肠道微生物的双相情感障碍生物标志物及其筛选应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5376668A (en) * 1990-08-21 1994-12-27 Novo Nordisk A/S Heterocyclic compounds
FI960747A7 (fi) * 1993-08-19 1996-04-17 Novo Nordisk As Antipsykoottinen menetelmä
US5672709A (en) * 1994-10-24 1997-09-30 Eli Lilly And Company Heterocyclic compounds and their preparation and use
US5488056A (en) * 1994-10-31 1996-01-30 Eli Lilly And Company Method for treating anxiety
JPH10508028A (ja) * 1994-10-31 1998-08-04 イーライ・リリー・アンド・カンパニー 不安を治療する方法

Also Published As

Publication number Publication date
PT821955E (pt) 2002-07-31
EP0821955A3 (de) 1998-04-22
DK0821955T3 (da) 2002-03-18
DE69710526D1 (de) 2002-03-28
NO990436D0 (no) 1999-01-29
EP0821955A2 (de) 1998-02-04
ATE213413T1 (de) 2002-03-15
BR9710901A (pt) 1999-08-17
DE69710526T2 (de) 2002-10-02
JP2000515547A (ja) 2000-11-21
AU4046897A (en) 1998-02-25
WO1998005324A1 (en) 1998-02-12
CZ27299A3 (cs) 1999-08-11
AU716972B2 (en) 2000-03-09
HUP9904578A2 (hu) 2000-06-28
ES2171838T3 (es) 2002-09-16
CN1226165A (zh) 1999-08-18
EA199900174A1 (ru) 1999-08-26
CA2261802A1 (en) 1998-02-12
KR20000029647A (ko) 2000-05-25
PL331407A1 (en) 1999-07-19
EP0821955B1 (de) 2002-02-20
CA2261802C (en) 2006-11-07
NO990436L (no) 1999-01-29

Similar Documents

Publication Publication Date Title
SG47520A1 (en) New method for the production of 9-amino-6-demethyl-6-deoxytetracycline
TW269678B (de)
HU9301362D0 (en) Method for producing 4-aryl-piperazines and 4-aryl-piperidines
IL119118A0 (en) 9-Ú(Haloacyl) amido¾-7- (substituted)-6- demethyl-6-deoxytetracycline intermediates
GB9722520D0 (en) Compounds
CY2543B1 (en) 9-Ä(Substituted glycyl)amidoÜ-6-(substituted)-5-hydroxy-6-deoxytetracyclines
IL106676A0 (en) Novel 7-(substituted)-8-(substituted-9-(substituted glycyl)amido)-6-demethyl-6-deoxytetracyclines
GB9406857D0 (en) Improvements in or relating to organic compounds
HU9403311D0 (en) NEW 7BéTA-SUBSTITUTED-4-AZA-5ALPHA-CHOLESTAN-ONES AS 5-ALPHA-REDUCTASE INHIBITORS
ATE240305T1 (de) Verfahren zur herstellung von 2- hydroxybenzamidderivaten
EP0924199A4 (de)
TW287103B (de)
IL115605A (en) Method for purifying keratinocyte growth factors
PL286043A1 (en) Method for manufacturing new proteins
IL128280A0 (en) Method fro treating bipolar disorder
IL128028A0 (en) Treatment of psychotic disorders
PL335186A1 (en) Method of treating an iron salts containing solution
MY133014A (en) Method for treating copd
ZA958609B (en) Method for purifying keratinocyte growth factors
TW277059B (de)
ZA983298B (en) Methods for reducing fibrinogen.
DE69711506D1 (de) Methylsulfomycin 1, Verfahren zu dessen Herstellung und Verwendung
GR3036968T3 (en) Adamantyl substituted oxindoles as pharmaceutical agents